How to build an effective protein degrader

March 31, 2021

Working in PROTACs, you’re tasked with the most challenging targets — that aim to address intractable diseases such as cancer, Alzheimer's, or Parkinson's disease. Despite the impressive promise of PROTACs, you still have to overcome many hurdles in order to work with these difficult targets.

This guide highlights the four major stages of targeted protein degradation, the challenges at each step, and questions you should ask yourself to make sure your final product will result in a complete protein degradation.

Download this guide to learn:

  • What are the most common roadblocks at key stages in PROTAC development
  • What methods and technologies help you overcome these challenges
  • What outcomes you should expect at each stage
Previous
Tackle undruggable targets by screening for binary and ternary PROTAC interactions using Dianthus
Tackle undruggable targets by screening for binary and ternary PROTAC interactions using Dianthus

Up next
Protein degraders show promising results in drug development pipelines. See progress candidates have made.
Protein degraders show promising results in drug development pipelines. See progress candidates have made.

There has been considerable and promising development in the field of targeted protein degradation (TPD) si...

Ready to tackle your challenging affinity screening?

Discover tools you can use

Learn more